Sector ratings Bio-Rad Laboratories, Inc.

Stocks

Market Closed - NYSE 06:00:02 29/08/26 am AEST			5-day change	1st Jan Change
387.70 ^USD	-0.57%		+2.02%	+27.96%

07/08	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT
05/08	RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI	Global Valuation
BIO-RAD LABORATORIES, INC.	10.25B	BBB	-
ABBOTT LABORATORIES	195B	BBB
MEDTRONIC PLC	117B	BBB
CENCORA, INC.	61.45B	AA
BECTON, DICKINSON AND COMPANY	51.62B	A
HOYA CORPORATION	51.03B	AAA
DEXCOM, INC.	34.27B	BBB
MEDLINE INC.	30.95B	A
WEST PHARMACEUTICAL SERVICES, INC.	23.75B	AA
TERUMO CORPORATION	23.41B	AA
STERIS PLC	22.79B	AAA	-
SARTORIUS STEDIM BIOTECH	22.32B	BBB
ZIMMER BIOMET HOLDINGS, INC.	19.25B	A
SOLVENTUM CORPORATION	15.51B	BBB
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED	15.23B	A
BAXTER INTERNATIONAL INC.	13.51B	A
ALIGN TECHNOLOGY, INC.	11.19B	A
GLOBUS MEDICAL, INC.	11.14B	CCC
INSULET CORPORATION	10.07B	A
REPLIGEN CORPORATION	9.95B	AA
Average	37.46B	A
Weighted average by Cap.		A